11th Annual Meeting of The Photomedicine Society

Thursday, February 21st, 2002
Grand Ballroom D, Hilton Riverside Hotel, New Orleans, LA, USA

OPENING REMARKS (Grand Ballroom D): Warwick L. Morison, M.D.

ORAL SESSION I (Grand Ballroom D): (Top)

8:05 - 8:15 Abstract 12
UVA-1 for the treatment of chronic hand dermatitis. Bergamo B, Elmets C. University of Alabama at Birmingham, Birmingham, Alabama, USA.

8:15 - 8:25 Abstract 14
The time-course of TL-01 UVB erythema. Man I, Dawe RS, Ferguson J, Ibbotson S. Ninewells Hospital and Medical School, Dundee, United Kingdom.

8:25 - 8:35 *Abstract 23
Multiple exposures to blue light does not improve psoriasis in patients with elevated endogenous levels of protoporphyrin IX. Maari C, Bissonnette R. University of Montreal Hospital Centre, Montreal, Quebec, Canada.

8:35 - 8:45 Abstract 10
Two broadspectrum SPF 15 sunscreens offer different protection against UV induced depression of delayed type hypersensitivity response in humans. Moyal D. L'Oréal Recherche, Clichy, France.

8:45 - 8:55 Abstract 1
Effect of UV on the susceptibility of acid-soluble SKH - 1 hairless mouse collagen to collagenase. Menter JM, Cornelison LM, Patta AM, Sayre RM, Abukhalaf IK, Silvestrov NS, Willis I. Morehouse School of Medicine, Atlanta, Georgia; and Rapid Precision Testing Laboratories, Memphis, Tennessee, USA.

8:55 - 9:05 Abstract 13
UVB dose and cell cycle conditions influence the outcome of UVB-induced HIV activation. Breuer-McHam J, Cruz PD Jr, Zhang CL, Actor J, Lewis DE, Duvic M. MD Anderson Cancer Center, Houston, Texas; Baylor College of Medicine, Houston, Texas; The University of Texas Southwestern Medical Center, Dallas, Texas, USA.

9:05 - 9:15 Abstract 19
Daily non-solar UV exposure. Sayre RM, Dowdy JC. Rapid Precision Testing Laboratories, Cordova, Tennessee; The University of Tennessee Center for Health Sciences, Memphis, Tennessee, USA.

9:15 - 9:45 BREAK FOR COFFEE AND POSTER VIEWING (Grand Salon 7)

ORAL SESSION II (Grand Ballroom D): (Top)

9:45 - 9:55 *Abstract 11
Adult onset erythropoietic protoporphyria in association with myelodysplastic syndrome. Spann CT, Tok J, Nimer S, Zug K, Deleo V. St. Luke's Roosevelt Hospital Center, Columbia University College of Physicians and Surgeons and Memorial Sloan-Kettering Hospital, New York, New York, USA.

9:55 -10:05 *Abstract 6
UVB emitting fiber optic hair brush for the treatment of scalp psoriasis. Taneja A, Trehan M., Gupta S, Racette A, Regan S, Gourgouliatos Z, Taylor CR. Massachusetts General Hospital, Boston, Massachusetts, USA.

10:05-10:15 *Abstract 7
308 NM excimer laser for the treatment of scalp psoriasis. Gupta S, Taneja A, Racette A, Trehan M, Taylor CR. Massachusetts General Hospital, Boston, Massachusetts, USA.

10:15-10:25 Abstract 18
The colipa standard for solar simulators failed to standardize sunscreen SPFS. Sayre RM. Rapid Precision Testing Laboratories, Cordova, Tennessee; The University of Tennessee Center for Health Sciences, Memphis, Tennessee, USA.

10:25-10:35 Abstract 9
In-vivo determination of UVA sunscreen efficacy using diffuse reflectance spectroscopy. Moyal D, Chardon A. L'Oréal Recherche, Clichy, France.

10:35-10:45 Abstract 20
Validation of in vivo and in vitro methods to measure UVA protectiveness of sunscreen. Cole C, Natter F, Ruvoio E, Issachar N. Johnson & Johnson Consumer Products Worldwide, Skillman, New Jersey, USA.

10:45-11:00 BREAK FOR COFFEE AND POSTER VIEWING (Grand Salon 7)
ORAL SESSION III (Grand Ballroom D) (Top)

11:00-11:10 Abstract 21
Skin aging and photoaging effects can be quantified in vivo by fluorescence excitation. Kollias N, Stamatas G. Johnson & Johnson Consumer Products Worldwide, Skillman, New Jersey, USA.

11:10-11:20 *Abstract 22
Efficacy of photochemotherapy and UVA1 therapy in patients with morphea or lichen sclerosus. Ghoreschi K, Röcken M. Ludwig-Maximilians University of Munich, Munich, Germany.

11:20-11:30 Abstract 16
Photodynamic therapy of non-melanoma skin cancers with verteporfin and red light-tumor response and cosmetic outcome. Lui H, Hobbs L, Tope W, Elmets C, Provost N, Lee P, Herne K, Mclean D, Hamzavi I, Jain H, Bissonnette R. University of British Columbia, Vancouver, British Columbia, Canada; The University of Minnesota, Minneapolis/St. Paul, Minnesota; The University of Alabama, Birmingham, Alabama, USA; The University of Montreal, Montreal, Quebec, Canada.

11:30-12:30 GUEST SPEAKER: Susan Fischer Ph.D. "Cyclooxygenase as a Target for Prevention of UV induced Skin Carcinogenesis"
(Top)

12:30-1:45 LUNCH AND POSTER VIEWING
(Board of Directors meeting at lunch)

SPECIAL TOPICS (Grand Ballroom D)

1:45-2:45 Pulse Dye and 308 nm laser therapy for psoriasis: Moderated by Warwick Morison, MD (Top)
2:45-3:45 Why isn't PDT therapy a killer app? Moderated by Harvey Lui, MD
Panel Members: Whitney Tope, M.D., Rolf-Markus Szeimies, M.D.

(Top)3:45-4:00 BREAK

4:00-4:15 Results of the Phototherapy Treatment Center Survey by Colby C. Evans, MD and Ponciano D. Cruz, Jr. MD

4:15-4:45 POSTER DISCUSSION: (Grand Salon 7) Moderated by Michael Zanolli, MD
(Top)

Abstract 3
Topical photodynamic therapy in dermatology - three years experience at Beaumont Hospital. Collins S, Ahmadi S, Murphy GM. Beaumont Hospital, Dublin, Ireland.

Abstract 2
Evaluation of the 'NASA' garment for children with xeroderma pigmentosum. Sayre RM, Dowdy JC, Stanfied J, Menter JM, Hatch KL. Rapid Precision Testing Laboratories, Cordova, Tennessee; The University of Tennessee Center for Health Sciences and Suncare Research Laboratory, Memphis, Tennessee; Morehouse School of Medicine, Atlanta, Georgia; The University of Arizona, Tucson, Arizona, USA.

Abstract 17
New source for evaluating PDT drugs in the laboratory. Sayre RM, Dowdy JC, Gart M. Rapid Precision Testing Laboratories, Cordova, Tennessee; The University of Tennessee Center for Health Sciences, Memphis, Tennessee; Lumacare, Inc, Newport Beach, California, USA.

*Abstract 4
Late onset congenital erythropoietic porphyria (Gunther’s disease). Kontos A, Ozog D, Lim HW. Henry Ford Health System, Detroit, Michigan, USA.

*Abstract 5
Polymorphous light eruption (PMLE) in African-Americans presenting as pinpoint papules. Kontos A, Cusack C, Lim HW. Henry Ford Health System, Detroit, Michigan, USA.

4:45 POSTER AWARDS PRESENTATION

5:30-8:00 COCKTAIL/RECEPTION: In conjunction with the American Contact Dermatitis Society